Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
- DOI
- 10.1007/s10555-017-9668-y
- Published
- 2017-06
- Container
- Cancer and Metastasis Reviews
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10555-017-9668-y,
title = {Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis},
author = {E. J. van Helden and C. W. Menke-van der Houven van Oordt and M. W. Heymans and J. C. F. Ket and R. van den Oord and H. M. W. Verheul},
year = {2017},
journal = {Cancer and Metastasis Reviews},
doi = {10.1007/s10555-017-9668-y},
url = {https://doi.org/10.1007/s10555-017-9668-y}
}RIS
TY - JOUR TI - Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis AU - E. J. van Helden AU - C. W. Menke-van der Houven van Oordt AU - M. W. Heymans AU - J. C. F. Ket AU - R. van den Oord AU - H. M. W. Verheul PY - 2017 JO - Cancer and Metastasis Reviews DO - 10.1007/s10555-017-9668-y UR - https://doi.org/10.1007/s10555-017-9668-y ER -
APA
Helden, E. J. V., Oordt, C. W. M. D. H. V., Heymans, M. W., Ket, J. C. F., Oord, R. V. D., & Verheul, H. M. W. (2017). Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-017-9668-y
Source records
- crossref · retrieved 2026-09-26T12:04:47.687Z